Target intelligence / Profile preview

Vertebrae development associated protein (Vertnin) (VRTN)

Target
VRTN
Molecular classification
Transcription factor, DNA-binding protein
01

Overview

Vertebrae development associated protein (Vertnin, VRTN) is a nuclear DNA-binding transcription factor conserved in mammals which regulates the development of thoracic vertebrae[7][2]. It acts during embryogenesis, where it is specifically expressed at the thoracic-somite stage and is indispensable for formation and segmentation of thoracic vertebrae and ribs. In animal models, VRTN modulates the segmentation clock through the Notch signaling pathway, coordinating somite formation and vertebral segmentation[1]. Variants in VRTN influence vertebral number in livestock, with significant agricultural impact. In mice, homozygous deficiency causes embryonic lethality while heterozygous animals may show abnormal spinal development and kyphosis[1]. The canonical molecular role of VRTN is as a transcription factor rather than a classical therapeutic target; no drugs are known to modulate its function and no validated clinical biomarkers or safety modalities exist for direct modulation[2][7].

Other names
VertninVRTNC14orf115FLJ10811Vertebrae development associated homolog (pig)Vertebrae development associated protein
02

Mechanism of action

Not applicable; no known drugs directly target VRTN

03

Biological functions

Regulation of transcription by RNA polymerase IISequence-specific DNA bindingControl of thoracic vertebrae developmentRegulation of somite segmentation during embryogenesis, particularly via the Notch signaling pathway
04

Disease associations

Causing abnormal vertebral segmentation (evidence in animal models)Associated with Usher syndrome type IIIaAssociated with Ulnar-mammary syndromeRole in embryonic lethality if absent (mouse model)Null allele/haploinsufficiency leads to congenital spinal defects
05

Safety considerations

Embryonic lethality with homozygous knockout in animal modelsHaploinsufficiency leads to spinal malformations and kyphosis in mice
06

Interacting drugs

None reported; VRTN is not a known drug target
07

Biomarkers

Variants (QTN) in regulatory regions of VRTN influence thoracic vertebral number in pigs, a trait used for genetic selection in agricultureNo clinical biomarkers for human patient selection or monitoring are established

Beyond the preview

Go deeper on Vertebrae development associated protein (Vertnin) (VRTN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vertebrae development associated protein (Vertnin) (VRTN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call